Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.89 CAD | -0.17% | -0.17% | +2.26% |
Mar. 11 | National Bank Revises 2024, 2025 Estimates for Dexterra Group Following Q4 Results | MT |
Mar. 11 | Dexterra Upgraded to Outperform at Raymond James | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.26% | 276M | |
+6.64% | 69.42B | |
+11.02% | 50.54B | |
+11.59% | 16.25B | |
+16.72% | 15.31B | |
+20.75% | 11.17B | |
+33.07% | 9.7B | |
+13.56% | 5.05B | |
+8.26% | 4.64B | |
+24.16% | 3.79B |
- Stock Market
- Equities
- DXT Stock
- News Dexterra Group Inc.
- Dexterra Group Brief: Target Upped To C$9.50 From $9 and Outperform Rating Unchanged at National Bank As Q3 Adds "Fuel to the Fire; National Notes WAFES to "Normalize Following Outlier Quarter"